CCL15 and non-small cell lung carcinoma: We investigated the relationship between NSCLC and the levels of various inflammation cytokines and found that interleukin (IL)1B (113.91 ± 21.59 vs. 21.87 ± 3.48), CXCL8 (1985.23 ± 438.51 vs. 430.08 ± 27.02), CXCL10 (2,819.79 ± 654.58 vs. 1,016.33 ± 70.82), and VEGF (981.78 ± 149.74 vs. 328.88 ± 42.79) were significantly elevated, and CCL15 (3,420.97 ± 317.86 vs. 4,672.99 ± 587.21) and IL15 (43.07 ± 2.71 vs. 59.73 ± 11.88) were significantly downregulated (Figure 2B).